QuidelOrtho price target lowered to $12 from $17 at UBS

UBS analyst Lu Li lowered the firm’s price target on QuidelOrtho (QDEL) to $12 from $17 and keeps a Neutral rating on the shares. The firm updated its model and tells investors in a research note that the overhang is likely to persist.